The post Twice Scores A New Hit Thanks To One Of The Biggest Movies Of 2025 appeared on BitcoinEthereumNews.com. Twice reaches the U.K.’s streaming songs chart for the second time ever as “Strategy” joins “Takedown,” with both climbing thanks to KPop Demon Hunters. SEOUL, SOUTH KOREA – JANUARY 23: Members of girl group TWICE attend the 8th Gaon Chart K-Pop Awards on January 23, 2019 in Seoul, South Korea. (Photo by Han Myung-Gu/WireImage) WireImage Twice continues to find space on several charts in the United Kingdom, and the group’s presence comes thanks to its pair of contributions to Netflix’s animated musical KPop Demon Hunters. Both cuts, “Takedown” and “Strategy,” have connected with listeners globally, and especially in the European nation, where this frame, one cut improves while the other eases downward. “Takedown” Hits a New Chart Peak “Takedown” climbs on two charts this week, including the most important one. The song improves from No. 31 to No. 27 on the Official Singles chart, granting Twice a new career high in the U.K. after five weeks on the tally. The same poppy cut also rises to No. 74 on the Official Streaming chart. Just like on the Official Singles list, Twice reaches another top spot on that roster as well. “Takedown” Declines When it Comes to Sales At the same time that it hits its new peaks on several tallies, “Takedown” also slides on sales-based lists. The tune falls from No. 67 to No. 87 on the Official Singles Sales chart and from No. 64 to No. 84 on the Official Singles Downloads ranking. Even as purchases backtrack, overall consumption of “Takedown” is growing in the U.K. “Strategy” Slips “Strategy” weakens on the Official Singles chart, dropping from No. 35 to No. 39 in its fifth frame on the consumption-based roster. The cut recently broke into the top 40 for the first time, at which point Twice claimed a pair… The post Twice Scores A New Hit Thanks To One Of The Biggest Movies Of 2025 appeared on BitcoinEthereumNews.com. Twice reaches the U.K.’s streaming songs chart for the second time ever as “Strategy” joins “Takedown,” with both climbing thanks to KPop Demon Hunters. SEOUL, SOUTH KOREA – JANUARY 23: Members of girl group TWICE attend the 8th Gaon Chart K-Pop Awards on January 23, 2019 in Seoul, South Korea. (Photo by Han Myung-Gu/WireImage) WireImage Twice continues to find space on several charts in the United Kingdom, and the group’s presence comes thanks to its pair of contributions to Netflix’s animated musical KPop Demon Hunters. Both cuts, “Takedown” and “Strategy,” have connected with listeners globally, and especially in the European nation, where this frame, one cut improves while the other eases downward. “Takedown” Hits a New Chart Peak “Takedown” climbs on two charts this week, including the most important one. The song improves from No. 31 to No. 27 on the Official Singles chart, granting Twice a new career high in the U.K. after five weeks on the tally. The same poppy cut also rises to No. 74 on the Official Streaming chart. Just like on the Official Singles list, Twice reaches another top spot on that roster as well. “Takedown” Declines When it Comes to Sales At the same time that it hits its new peaks on several tallies, “Takedown” also slides on sales-based lists. The tune falls from No. 67 to No. 87 on the Official Singles Sales chart and from No. 64 to No. 84 on the Official Singles Downloads ranking. Even as purchases backtrack, overall consumption of “Takedown” is growing in the U.K. “Strategy” Slips “Strategy” weakens on the Official Singles chart, dropping from No. 35 to No. 39 in its fifth frame on the consumption-based roster. The cut recently broke into the top 40 for the first time, at which point Twice claimed a pair…

Twice Scores A New Hit Thanks To One Of The Biggest Movies Of 2025

For feedback or concerns regarding this content, please contact us at [email protected]

Twice reaches the U.K.’s streaming songs chart for the second time ever as “Strategy” joins “Takedown,” with both climbing thanks to KPop Demon Hunters. SEOUL, SOUTH KOREA – JANUARY 23: Members of girl group TWICE attend the 8th Gaon Chart K-Pop Awards on January 23, 2019 in Seoul, South Korea. (Photo by Han Myung-Gu/WireImage)

WireImage

Twice continues to find space on several charts in the United Kingdom, and the group’s presence comes thanks to its pair of contributions to Netflix’s animated musical KPop Demon Hunters. Both cuts, “Takedown” and “Strategy,” have connected with listeners globally, and especially in the European nation, where this frame, one cut improves while the other eases downward.

“Takedown” Hits a New Chart Peak

“Takedown” climbs on two charts this week, including the most important one. The song improves from No. 31 to No. 27 on the Official Singles chart, granting Twice a new career high in the U.K. after five weeks on the tally.

The same poppy cut also rises to No. 74 on the Official Streaming chart. Just like on the Official Singles list, Twice reaches another top spot on that roster as well.

“Takedown” Declines When it Comes to Sales

At the same time that it hits its new peaks on several tallies, “Takedown” also slides on sales-based lists. The tune falls from No. 67 to No. 87 on the Official Singles Sales chart and from No. 64 to No. 84 on the Official Singles Downloads ranking. Even as purchases backtrack, overall consumption of “Takedown” is growing in the U.K.

“Strategy” Slips

“Strategy” weakens on the Official Singles chart, dropping from No. 35 to No. 39 in its fifth frame on the consumption-based roster. The cut recently broke into the top 40 for the first time, at which point Twice claimed a pair of concurrent top 40 singles — a rare feat for any K-pop group in the U.K. Now, it hovers near the edge of that region, and it may step outside it soon.

Twice Debuts “Strategy” as a Top Streamer

Even as “Strategy” slips, it also manages to debut. The track starts at No. 93 on the Official Streaming chart, becoming just the second Twice song to appear on the all-style roster. Both of the band’s streaming wins in the U.K. come from KPop Demon Hunters.

Source: https://www.forbes.com/sites/hughmcintyre/2025/09/02/twice-scores-a-new-hit-thanks-to-one-of-the-biggest-movies-of-2025/

Market Opportunity
Seed.Photo Logo
Seed.Photo Price(PHOTO)
$0.17399
$0.17399$0.17399
-1.91%
USD
Seed.Photo (PHOTO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09